DUSP-1 Knockout Cell Line (ID8)

The choice depends on whether you are studying DUSP1 (MKP-1, mitogen-activated protein kinase phosphatase 1)'s role as the prototypical dual-specificity MAPK phosphatase or modeling its functions in ovarian cancer and tumor immunology. The Knockout line is the standard tool for asking whether DUSP1 is required for these processes — DUSP1 is a dual-specificity phosphatase that dephosphorylates pT-X-pY motifs in the MAPK activation loop, primarily targeting p38 and JNK (with weaker activity on ERK); DUSP1 is an immediate-early gene induced by glucocorticoids, MAPK signaling, and stress, providing negative feedback on MAPK pathways. Overexpression is useful for studying DUSP1 gain-of-function effects. For ovarian tumor immunology research, the EDITGENE Dusp1 Knockout in ID8 is highly relevant — ID8 is a syngeneic murine ovarian cancer cell line widely used in C57BL/6 immune-competent mice for ovarian cancer immunotherapy research, and DUSP1 has emerged as an immune evasion factor in tumor biology. Other DUSP family member expression analysis aids interpretation. Rescue with wild-type or catalytically-dead DUSP1 enables structure-function studies. The knockout is valuable for studying MAPK pathway feedback regulation, glucocorticoid anti-inflammatory mechanisms (DUSP1 mediates dexamethasone anti-inflammatory effects), and emerging DUSP1-related tumor immunology.

Primary applications: • MAPK dephosphorylation: phospho-p38, phospho-JNK, phospho-ERK Western blot analysis to characterize DUSP1 phosphatase activity following stress stimuli. • Ovarian tumor immunology: ID8 implantation in C57BL/6 mice — Dusp1-null versus wild-type tumor growth and immune profiling. • Glucocorticoid mechanism: dexamethasone anti-inflammatory effects given DUSP1's role as a glucocorticoid-induced MAPK negative regulator. • MAPK feedback: assessment of MAPK signaling dynamics in DUSP1-null cells given the loss of negative feedback. EDITGENE recommends this ID8-based model for researchers investigating ovarian tumor immunology, MAPK pathway feedback, and glucocorticoid anti-inflammatory mechanisms.

Yes. DUSP1 rescue experiments are well-established for MAPK pathway research: • Construct design: use a codon-modified Dusp1 sequence with a small C-terminal tag (FLAG, HA). DUSP1 has N-terminal MAPK-binding domain (MKB/KIM/D-motif) and C-terminal dual-specificity phosphatase catalytic domain — preserve all elements. • Catalytically-dead rescue: C258S mutation in the catalytic cysteine abolishes phosphatase activity and serves as the standard specificity control. • MKB-mutant rescue: KIM/D-motif mutations disrupt MAPK substrate recognition without affecting catalytic activity. • Functional readout: rescue should restore p38/JNK dephosphorylation following stress stimulation. ID8-specific considerations: • ID8 is a murine ovarian surface epithelial cell line (spontaneously transformed C57BL/6 ovarian surface epithelium) — the principal syngeneic ovarian cancer model for in vivo tumor immunology studies in immunocompetent C57BL/6 hosts. • Lentiviral transduction is supported with moderate efficiency. • ID8 forms peritoneal disseminated tumors and ascites in syngeneic C57BL/6 mice, mimicking advanced human ovarian cancer biology.